Centiva Capital’s Indivior Pharmaceuticals INDV Stock Holding History

Centiva Capital’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-85,090	Closed	-$830K	–	2031
2024 Q3	$830K	Buy	85,090 +60,090	+240%	+$704K	0.04%	963
2024 Q2	$403K	Buy	25,000 +9,840	+65%	+$178K	0.02%	1294
2024 Q1	$325K	Buy	+15,160	New	+$285K	0.02%	1204

Other funds holding INDV

Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return

Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jefferies Financial Group New York $8.2B AUM 40.95% 1-Year Est. Return

Scopia Capital Management New York $144M AUM 25.93% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return